Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
about
Candidate genes for COPD: current evidence and researchUnderrecognized comorbidities of chronic obstructive pulmonary diseaseSystemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityReceptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels.Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke.The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes.AGER -429T/C is associated with an increased lung disease severity in cystic fibrosisSoluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in miceSmoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status.The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.Intake of high fructose corn syrup sweetened soft drinks is associated with prevalent chronic bronchitis in U.S. Adults, ages 20-55 y.Advanced glycation endproducts and their receptor in different body compartments in COPDEffect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD.Association of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese population.Lung damage and airway remodelling in severe asthma.Phenotyping the heterogeneity of chronic obstructive pulmonary disease.Circulating soluble receptor for advanced glycation end products (sRAGE) as a biomarker of emphysema and the RAGE axis in the lung.The influence of processed meat consumption on chronic obstructive pulmonary disease.Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokersThe IRONy of Iron-overload and Iron-deficiency in Chronic Obstructive Pulmonary Disease.All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.Oxidative stress markers are increased in patients with mastocytosis.Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: a case-cohort study and murine model of acute particulate exposureConditionally induced RAGE expression by proximal airway epithelial cells in transgenic mice causes lung inflammation.Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.Emphysema requires the receptor for advanced glycation end-products triggering on structural cells.What do polymorphisms tell us about the mechanisms of COPD?A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease.AGEs-RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis.Inverse Relationship Between Soluble RAGE and Risk for Bronchopulmonary Dysplasia.Acute secondhand smoke-induced pulmonary inflammation is diminished in RAGE knockout mice.Conditional overexpression of receptors for advanced glycation end-products in the adult murine lung causes airspace enlargement and induces inflammation.Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD.Relationship between advanced glycation end-product accumulation in the skin and pulmonary function.Embryonic overexpression of receptors for advanced glycation end-products by alveolar epithelium induces an imbalance between proliferation and apoptosis.Involvement of new oxidative stress markers in chronic spontaneous urticaria.Overexpression of RAGE contributes to cigarette smoke-induced nitric oxide generation in COPD.Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea.
P2860
Q26777324-A4790103-49AC-49D4-A8E6-C82177AD37F7Q26800282-DB076C25-584A-4971-A939-8A250C03CD22Q28728578-1E9A0866-FBB7-4349-B155-AFC4C9D6B59FQ33756371-FC68D4CB-8CCB-4A5F-A41D-C3946D091E1DQ33873927-CB08F47A-D614-4C75-9461-7536C8A66748Q34346490-C33521DF-216B-4679-825B-7E5A571EFDF1Q34364298-2A63ECE1-85EF-405F-8B58-DB95C0BE9030Q34774357-C95A0CEF-15B3-4CF4-BBB0-FE70B15D3696Q35190905-A4A521D5-3E09-4CB3-8030-A8CF21E93137Q36162963-5377F420-8E63-4D76-A6FB-76AF1F7827D9Q36166108-1E7E818A-ABF5-4243-B177-16C0AEE34833Q36171889-EC509ACC-C3EC-426D-8520-3E87FE324A94Q36842527-9918C2C9-F955-44C4-AD74-5015D5C956D5Q37404091-FD1CE948-0854-4047-997B-9BF4A000E1C6Q37620204-E6A03BB1-5754-46BB-952E-702873554DECQ37667568-DF1B5171-B411-4F90-ACF6-3C9C5844E010Q37970841-7C2B609C-9BE9-481B-B638-F9E8824ABF84Q38063326-BACB9613-D46F-4BCE-AE86-FC47AE85DAAEQ38541559-1C1E5444-83FE-4968-9DAE-FD579DDAE026Q38616696-9FD681DF-4EF7-4FBB-B06B-C20C898158B0Q38661408-0E1DB6C0-4314-497F-AD88-0FC12A918EE5Q39243181-34A3993A-A71A-4484-9E35-7EAA2CA0083AQ39246681-72AC2371-3181-4F78-8785-0D05A8743804Q41512689-7C6B5AC5-CBDA-4AEB-84A8-264C415994E3Q41571383-F87A0024-9DA5-4A92-A475-E329814F7C0FQ42106315-EB0A613C-04B0-4184-99EC-7A78E0FEA7E5Q43779676-10069928-F6AF-468D-A364-63ACF3DEE37BQ46188793-475B0445-869B-4D8C-B6B4-A72ED5414B3BQ47801457-49CDCF0A-01AD-4ECD-880D-24CEA03663B0Q47998588-B55693D7-1A73-4761-AE05-98E278F49F64Q48225516-0D20A8E7-66B4-4163-AFCE-DB111F999BD7Q50073081-D355E377-C2EF-42C3-AE50-0D283320F3AFQ50632076-42060B4C-87D6-406F-BE58-99DB20E3819FQ50752074-C0EAB02C-0077-4D34-AC4E-BE314F4DD8E1Q51528753-36E7091A-FF69-4102-B4B0-6257746E8F06Q51759218-D7494DF8-A466-4649-8019-E9AB7FEACCC4Q51813931-708CA4B7-7CE4-4C38-BA93-B52AC6FF32A7Q52673048-21C3E7C9-9005-4DBC-BB64-8DC1644E9DF8Q53066000-67098BD4-4F44-4CED-ACA7-1740DE7FB99FQ53828969-C9944EBA-3FD7-4831-A28F-7A31FE27C1B1
P2860
Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Advanced glycation end product ...... creased in patients with COPD.
@ast
Advanced glycation end product ...... creased in patients with COPD.
@en
Advanced glycation end products and its receptor
@nl
type
label
Advanced glycation end product ...... creased in patients with COPD.
@ast
Advanced glycation end product ...... creased in patients with COPD.
@en
Advanced glycation end products and its receptor
@nl
prefLabel
Advanced glycation end product ...... creased in patients with COPD.
@ast
Advanced glycation end product ...... creased in patients with COPD.
@en
Advanced glycation end products and its receptor
@nl
P2093
P1433
P1476
Advanced glycation end product ...... creased in patients with COPD.
@en
P2093
Louise F B Nicholson
Peter N Black
P304
P356
10.1016/J.RMED.2010.11.001
P577
2010-11-26T00:00:00Z